ClinicalTrials.gg
CompletedNCT00253253Updated May 22, 2008

Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy

An observational study in Undescended Testis, sponsored by Medical Center Alkmaar. Completed at 1 site in Netherlands. Open to male participants aged 6 Months to 25 Years. Per ClinicalTrials.gov, last updated 2008-05-22.

Sponsored by Medical Center Alkmaar · Observational

Study type
Observational
Time perspective
Retrospective
Enrollment
181
Ages
6 Months to 25 Years
Sex
Male
01

Study summary

The purpose of this study is to determine the long-term outcome in congenital undescended testis after surgical treatment by orchidopexy and to what extent orchidopexy is the treatment for congenital undescended testis.

02

Conditions studied

  • Undescended Testis

Browse trials for

Keywords

  • orchidopexy, long-term outcome, congenital
03

In context

Cryptorchidism

40 studies on the registry are indexed under Cryptorchidism; 14 are open to participants now.

This study's enrollment of 181 is above the median of 100 across 14 observational studies indexed under Cryptorchidism.

Browse Cryptorchidism studies →

Lead sponsor

Medical Center Alkmaar is the lead sponsor of 20 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The orchidopexy has taken place in the Medical Center Alkmaar between 1986-2004
  • The indication concerned a congenital undescended testis
  • It concerns a first orchidopexy to the concerning testis

Exclusion criteria

Exclusion Criteria:

  • Orchidopexy has taken place on an other reason than congenital undescended testis (for example: torsio testis)
  • It concerns re-orchidopexy
05

Study design

Time perspective
Retrospective
Enrollment
181 participants (actual)
06

Study locations

1 site
  • Medical Center Alkmaar
    Alkmaar, Noord-Holland 1815 J D, Netherlands
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2006 and a completion of Jan 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2005
First posted
Nov 15, 2005
Start
Aug 2006
Completion
Jan 2007
Last update
May 22, 2008
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
No changes since tracking began. The registry record was last updated on May 22, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00253253
Lead sponsor
Medical Center Alkmaar
First posted
Nov 15, 2005
Start date
Aug 2006
Completion
Jan 2007
Last update
May 22, 2008

Study contacts

W.W. M. Hack, MD, PhD
study director · Department of Pediatrics, Medical Centre Alkmar
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion